China Universal Asset Management Co., Ltd. Biotechnology

China Universal Asset Management Co., Ltd.

$1.03 Billion
Q2 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
VRTX Vertex Pharmaceuticals Inc	$99.7B	$19.7 Million 1.91% of portfolio	44,265	Q2 2025 Reduced 9.42%
REGN Regeneron Pharmaceuticals, Inc.	$59.6B	$12.9 Million 1.25% of portfolio	24,537	Q2 2025 Reduced 4.26%
ALNY Alnylam Pharmaceuticals, Inc.	$57.7B	$9.07 Million 0.88% of portfolio	27,817	Q2 2025 Reduced 10.18%
INSM Insmed Inc	$19.8B	$3.68 Million 0.36% of portfolio	36,582	Q2 2025 Added 0.76%
ARGX Argenx Se	$42.2B	$3.49 Million 0.34% of portfolio	6,335	Q2 2025 Reduced 1.34%
SMMT Summit Therapeutics Inc.	$3.69B	$3.17 Million 0.31% of portfolio	149,162	Q2 2025 Added 0.81%
RPRX Royalty Pharma PLC	$15.8B	$3.05 Million 0.3% of portfolio	84,631	Q2 2025 Reduced 2.63%
RVMD Revolution Medicines, Inc.	$3.55B	$2.85 Million 0.28% of portfolio	77,411	Q2 2025 Reduced 13.95%
INCY Incyte Corp	$19.2B	$2.65 Million 0.26% of portfolio	38,878	Q2 2025 Added 0.15%
UTHR United Therapeutics Corp	$18B	$2.6 Million 0.25% of portfolio	9,059	Q2 2025 Added 0.56%
EXEL Exelixis, Inc.	$12.1B	$2.41 Million 0.23% of portfolio	54,772	Q2 2025 Reduced 2.44%
VRNA Verona Pharma PLC	$6.48B	$2.17 Million 0.21% of portfolio	22,961	Q2 2025 Reduced 0.03%
MRNA Moderna, Inc.	$9.51B	$2.14 Million 0.21% of portfolio	77,676	Q2 2025 Reduced 0.66%
BMRN Biomarin Pharmaceutical Inc	$10.1B	$2.14 Million 0.21% of portfolio	38,890	Q2 2025 Added 0.65%
BNTX Bio N Tech Se	$24.5B	$2.14 Million 0.21% of portfolio	20,065	Q2 2025 Added 0.14%
ASND Ascendis Pharma A/S	$11.1B	$2.1 Million 0.2% of portfolio	12,186	Q2 2025 Added 0.6%
BGNE Bei Gene, Ltd.	$23.5B	$1.88 Million 0.18% of portfolio	8,293	Q2 2025 Reduced 1.2%
BPMC Blueprint Medicines Corp	$7.73B	$1.66 Million 0.16% of portfolio	12,971	Q2 2025 Added 1.19%
BBIO Bridge Bio Pharma, Inc.	$7.85B	$1.65 Million 0.16% of portfolio	38,137	Q2 2025 Reduced 0.03%
ROIV Roivant Sciences Ltd.	$9.7B	$1.54 Million 0.15% of portfolio	136,536	Q2 2025 Reduced 4.6%
MDGL Madrigal Pharmaceuticals, Inc.	$7.36B	$1.35 Million 0.13% of portfolio	4,459	Q2 2025 Added 0.68%
JAZZ Jazz Pharmaceuticals PLC	$7.95B	$1.31 Million 0.13% of portfolio	12,383	Q2 2025 Added 1.65%
HALO Halozyme Therapeutics, Inc.	$10.6B	$1.29 Million 0.12% of portfolio	24,748	Q2 2025 Added 0.19%
IONS Ionis Pharmaceuticals Inc	$9.08B	$1.26 Million 0.12% of portfolio	31,966	Q2 2025 Added 0.25%
PTGX Protagonist Therapeutics, Inc	$2.83B	$1.05 Million 0.1% of portfolio	18,908	Q2 2025 Added 0.72%
PCVX Vaxcyte, Inc.	$1.9B	$1.04 Million 0.1% of portfolio	31,910	Q2 2025 Added 23.55%
AXSM Axsome Therapeutics, Inc.	$5.32B	$1.03 Million 0.1% of portfolio	9,889	Q2 2025 Added 1.09%
NUVL Nuvalent, Inc.	$3.37B	$1.02 Million 0.1% of portfolio	13,331	Q2 2025 Added 0.45%
KYMR Kymera Therapeutics, Inc.	$2.38B	$1.01 Million 0.1% of portfolio	23,079	Q2 2025 Added 77.16%
IMVT Immunovant, Inc.	$3.55B	$944,000 0.09% of portfolio	34,329	Q2 2025 Added 0.76%
ADMA Adma Biologics, Inc.	$3.09B	$873,000 0.08% of portfolio	47,949	Q2 2025 Added 1.12%
AKRO Akero Therapeutics, Inc.	$2.01B	$854,000 0.08% of portfolio	16,011	Q2 2025 Added 0.26%
CRSP Crispr Therapeutics Ag	$4.04B	$843,000 0.08% of portfolio	17,346	Q2 2025 Added 0.82%
RYTM Rhythm Pharmaceuticals, Inc.	$5.65B	$807,000 0.08% of portfolio	12,778	Q2 2025 Added 0.76%
KRYS Krystal Biotech, Inc.	$3.53B	$797,000 0.08% of portfolio	5,804	Q2 2025 Added 0.45%
CYTK Cytokinetics Inc	$4.9B	$792,000 0.08% of portfolio	23,987	Q2 2025 Added 0.99%
PTCT Ptc Therapeutics, Inc.	$4.17B	$777,000 0.08% of portfolio	15,918	Q2 2025 Added 0.62%
MRUS Merus N.V.	$3.08B	$731,000 0.07% of portfolio	13,901	Q2 2025 Added 0.31%
ACLX Arcellx, Inc.	$3.16B	$728,000 0.07% of portfolio	11,068	Q2 2025 Added 0.43%
ACAD Acadia Pharmaceuticals Inc	$3.85B	$725,000 0.07% of portfolio	33,614	Q2 2025 Added 0.48%
RARE Ultragenyx Pharmaceutical Inc.	$2.19B	$690,000 0.07% of portfolio	18,988	Q2 2025 Added 2.34%
RNA Avidity Biosciences, Inc.	$2.42B	$687,000 0.07% of portfolio	24,210	Q2 2025 Added 0.4%
SRRK Scholar Rock Holding Corp	$1.61B	$675,000 0.07% of portfolio	19,069	Q2 2025 Added 0.41%
WVE Wave Life Sciences Ltd.	$669M	$606,000 0.06% of portfolio	93,370	Q2 2025 Added 77.78%
LEGN Legend Biotech Corp	$5.6B	$582,000 0.06% of portfolio	16,406	Q2 2025 Added 0.13%
OCUL Ocular Therapeutix, Inc	$1B	$575,000 0.06% of portfolio	61,995	Q2 2025 Added 96.59%
CRNX Crinetics Pharmaceuticals, Inc.	$1.88B	$541,000 0.05% of portfolio	18,815	Q2 2025 Added 0.81%
MIRM Mirum Pharmaceuticals, Inc.	$2.75B	$506,000 0.05% of portfolio	9,949	Q2 2025 Added 1.2%
XENE Xenon Pharmaceuticals Inc.	$2.31B	$482,000 0.05% of portfolio	15,412	Q2 2025 Added 0.38%
IBRX Immunity Bio, Inc.	$1.03B	$467,000 0.05% of portfolio	177,271	Q2 2025 Added 21.04%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.